EARLY SCHIZOPHRENIA PATIENTS TREATED WITH ONCE-MONTHLY PALIPERIDONE PALMITATE OVER A 12-MONTH PERIOD - A RETROSPECTIVE OBSERVATIONAL STUDY

被引：0
|
作者：
Schreiner, A. [1 ]
Bergmans, P. [2 ]
Cherubin, P. [3 ]
Hargarter, L. [1 ]
机构：
[1] Janssen Cilag, EMEA Med Affairs, Neuss, Germany
[2] Janssen Cilag Benelux, Biostat & Programming, Tilburg, Netherlands
[3] Janssen Cilag, EMEA Med Affairs, Issy Les Moulineaux, France
来源：
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY | 2017年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：150 / 151
页数：2
相关论文
共 50 条
  • [41] Clinical response in patients treated with once-monthly paliperidone palmitate: analysis of a therapeutic drug monitoring (TDM) database
    Schoretsanitis, Georgios
    Haen, Ekkehard
    Piacentino, Daria
    Conca, Andreas
    Endres, Katharina
    Hiemke, Christoph
    Grunder, Gerhard
    Paulzen, Michael
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2021, 271 (08) : 1437 - 1443
  • [42] Clinical response in patients treated with once-monthly paliperidone palmitate: analysis of a therapeutic drug monitoring (TDM) database
    Georgios Schoretsanitis
    Ekkehard Haen
    Daria Piacentino
    Andreas Conca
    Katharina Endres
    Christoph Hiemke
    Gerhard Gründer
    Michael Paulzen
    European Archives of Psychiatry and Clinical Neuroscience, 2021, 271 : 1437 - 1443
  • [43] Relapse and Treatment Adherence in Patients with Schizophrenia Switching from Paliperidone Palmitate Once-Monthly to Three-Monthly Formulation: A Retrospective Health Claims Database Analysis
    Li, Gang
    Keenan, Alexander
    Daskiran, Mehmet
    Mathews, Maju
    Nuamah, Isaac
    Orman, Camille
    Joshi, Kruti
    Singh, Arun
    Godet, Annabelle
    Pungor, Katalin
    Gopal, Srihari
    PATIENT PREFERENCE AND ADHERENCE, 2021, 15 : 2239 - 2248
  • [44] A quantitative systems pharmacology study on optimal scenarios for switching to paliperidone palmitate once-monthly
    Geerts, Hugo
    Spiros, Athan
    Roberts, Patrick
    Alphs, Larry
    SCHIZOPHRENIA RESEARCH, 2018, 197 : 261 - 268
  • [45] EFFICACY AND SAFETY OF PALIPERIDONE PALMITATE ONCE-MONTHLY IN PATIENTS WITH SCHIZOPHRENIA WITH LOW, MODERATE, AND HIGH RECENT DISEASE ACTIVITY AT BASELINE
    Lynum, Karimah
    Turkoz, Ibrahim
    Kim, Edward
    SCHIZOPHRENIA BULLETIN, 2019, 45 : S317 - S318
  • [46] TREATMENT PATTERNS IN MEDICAID BENEFICIARIES WITH SCHIZOPHRENIA REACHING STABILIZED MAINTENANCE WITH ONCE-MONTHLY PALIPERIDONE PALMITATE THERAPY
    Pilon, D.
    Muser, E.
    Emond, B.
    Xiao, Y.
    Amos, T.
    Lefebvre, P.
    Benson, C.
    VALUE IN HEALTH, 2016, 19 (03) : A196 - A196
  • [47] Long-term efficacy and safety of paliperidone palmitate once-monthly in Chinese patients with recent-onset schizophrenia
    Si, Tianmei
    Zhuo, Jianmin
    Feng, Yu
    Lu, Huafei
    Hong, Di
    Zhang, Lili
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2019, 15 : 1685 - 1694
  • [48] Long-term tolerability of once-monthly injectable paliperidone palmitate in subjects with recently diagnosed schizophrenia
    Sliwa, Jennifer Kern
    Bossie, Cynthia A.
    Fu, Dong-Jing
    Turkoz, Ibrahim
    Alphs, Larry
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2012, 8 : 375 - 385
  • [49] Paliperidone Palmitate Once-Monthly Treatment in Recent Onset and Chronic Illness Patients With Schizoaffective Disorder
    Bossie, Cynthia A.
    Turkoz, Ibrahim
    Alphs, Larry
    Mahalchick, Lucy
    Fu, Dong-Jing
    JOURNAL OF NERVOUS AND MENTAL DISEASE, 2017, 205 (04) : 324 - 328
  • [50] Aripiprazole Once-monthly is Superior to Paliperidone Palmitate in a Randomized, Head-to-head Clinical Study
    Naber, D.
    Hansen, K.
    Forray, C.
    Baker, R. A.
    Sapin, C.
    Beillat, M.
    Peters-Strickland, T.
    Nylander, A. G.
    Hertel, P.
    Andersen, H. Steen
    Eramo, A.
    Loze, J. Y.
    Potkin, S.
    EUROPEAN PSYCHIATRY, 2015, 30
12345